You are here

  • Home
  • Archive
  • Volume 102, Issue Suppl 6
  • 36 Triple Therapy Anticoagulation following Percutaneous Coronary Intervention (PCI) with Novel Oral Anticoagulants (NOAC) is Safe and has no Adverse Effects on Bleeding Post Procedure when Compared to Triple Therapy with Vitamin K Antagonist (VKA)

Article metrics

Article menu

Download PDFPDF

Heart View
Interventional Cardiology
36 Triple Therapy Anticoagulation following Percutaneous Coronary Intervention (PCI) with Novel Oral Anticoagulants (NOAC) is Safe and has no Adverse Effects on Bleeding Post Procedure when Compared to Triple Therapy with Vitamin K Antagonist (VKA)
Free

 

Online download statistics by month:

Online download statistics by month: June 2016 to March 2024

AbstractFullPdf
Jun 201625012
Jul 20162608
Aug 2016400
Sep 201611115
Oct 20161603
Nov 201617012
Dec 20161101
Jan 20172109
Feb 20173007
Mar 20171002
Apr 201715023
May 2017906
Jun 20171506
Jul 20171803
Aug 20172802
Sep 20172000
Oct 20171604
Nov 20173802
Dec 20172605
Jan 20184001
Feb 20181603
Mar 20183805
Apr 20185001
May 20182802
Jun 20183801
Jul 20183000
Aug 20181801
Sep 20181201
Oct 20183608
Nov 20181603
Dec 20182401
Jan 20192600
Feb 20194202
Mar 20193009
Apr 20191603
May 20191402
Jun 20192001
Jul 20192003
Aug 20192404
Sep 20193206
Oct 20191601
Nov 20191002
Dec 20192400
Jan 20201203
Feb 20201401
Mar 2020203
May 2020803
Jun 20201200
Jul 20201004
Aug 2020203
Sep 20202202
Oct 2020402
Nov 2020603
Dec 2020800
Jan 2021402
Mar 20211206
Apr 20211201
May 2021101
Jun 2021001
Jul 2021003
Aug 2021006
Sep 2021003
Oct 20216013
Nov 202116014
Dec 2021200
Jan 20222604
Feb 2022801
Mar 20221401
Apr 2022302
May 20221407
Jun 20221602
Jul 2022800
Aug 20221201
Sep 2022605
Oct 20221305
Nov 20222003
Dec 20221301
Jan 2023603
Feb 2023400
Mar 2023600
May 20231005
Jun 2023400
Jul 2023407
Aug 2023606
Sep 20231803
Oct 2023400
Nov 2023602
Dec 20233401
Jan 2024204
Feb 2024400
Mar 2024600
Total13961317